A New Platinum-Based Prodrug Candidate for Chemotherapy and Its Synergistic Effect With Hadrontherapy: Novel Strategy to Treat Glioblastoma

Glioblastoma (GBM) is the most common tumor of the central nervous system. Current therapies, often associated with severe side effects, are inefficacious to contrast the GBM relapsing forms. In trying to overcome these drawbacks, (OC-6-44)-acetatodiamminedichlorido(2-(2-propynyl)octanoato)platinum(...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferrari, Beatrice, Roda, Elisa, Priori, Erica Cecilia, De Luca, Fabrizio, Facoetti, Angelica, Ravera, Mauro, Brandalise, Federico, Locatelli, Carlo Alessandro, Rossi, Paola, Bottone, Maria Grazia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019820/
https://www.ncbi.nlm.nih.gov/pubmed/33828444
http://dx.doi.org/10.3389/fnins.2021.589906

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019820/
https://www.ncbi.nlm.nih.gov/pubmed/33828444
http://dx.doi.org/10.3389/fnins.2021.589906

Ejemplares similares